Patients worldwide rely on Taj Pharma’s Anti-Cancer products to meet their medical needs. Ensuring an unrestricted supply of safe medicines is of critical importance to us, and doing so requires a secure, accountable supply chain of trusted partner companies. In 2018, Taj Pharma Oncology division completed audits of 9,892 suppliers globally, and more than 11,000 supplier audits were planned for 2019.